Literature DB >> 24495280

Levosimendan improves contractility in vivo and in vitro in a rodent model of post-myocardial infarction heart failure.

S M Kolseth1, N P L Rolim, Ø Salvesen, D O Nordhaug, A Wahba, M A Høydal.   

Abstract

AIM: As few studies have presented a thorough analysis of the effect of levosimendan (LEV) on contractility, our purpose was to investigate in vivo cardiac function as well as in vitro cardiomyocyte function and calcium (Ca(2+) ) handling following LEV treatment.
METHODS: Rats with post-myocardial infarction heart failure (HF) induced by ligation of the left anterior descending coronary artery and sham-operated animals were randomized to the infusion of LEV (2.4 μg kg(-1) min(-1) ) or vehicle for 40 min. Echocardiographic examination was coupled to pressure-volume sampling in the left ventricle before (B) and after (40 min) infusion. Isolated left ventricular cardiomyocytes were studied in an epifluorescence microscope.
RESULTS: HF LEV (n = 6), HF vehicle (n = 7), sham LEV (n = 5) and sham vehicle (n = 6) animals were included. LEV infusion compared to vehicle in HF animals reduced left ventricular end-diastolic pressure and mean arterial pressure (both P < 0.001) and improved the slope of the preload-recruitable stroke work (P < 0.05). Administrating LEV to HF cardiomyocytes in vitro improved fractional shortening and Ca(2+) sensitivity index ratio, and increased the diastolic Ca(2+) (all P < 0.01).
CONCLUSION: In HF animals, LEV improved the contractility by increasing the Ca(2+) sensitivity. Furthermore loading conditions were changed, and LEV could consequently change organ perfusion. An observed increase in diastolic Ca(2+) following LEV treatment and clinical implications of this should be further addressed.
© 2014 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Ca2+ sensitivity; Ca2+ transients; contractility; heart failure; inotropic drug; preload

Mesh:

Substances:

Year:  2014        PMID: 24495280     DOI: 10.1111/apha.12248

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  3 in total

1.  Fluorescence Based Characterization of Calcium Sensitizer Action on the Troponin Complex.

Authors:  William Schlecht; King-Lun Li; Dehong Hu; Wenji Dong
Journal:  Chem Biol Drug Des       Date:  2015-09-16       Impact factor: 2.817

2.  Association between Functional Variables and Heart Failure after Myocardial Infarction in Rats.

Authors:  Bertha F Polegato; Marcos F Minicucci; Paula S Azevedo; Andréa F Gonçalves; Aline F Lima; Paula F Martinez; Marina P Okoshi; Katashi Okoshi; Sergio A R Paiva; Leonardo A M Zornoff
Journal:  Arq Bras Cardiol       Date:  2016-01-26       Impact factor: 2.000

3.  Low-Level Laser Application in the Early Myocardial Infarction Stage Has No Beneficial Role in Heart Failure.

Authors:  Martha T Manchini; Ednei L Antônio; José Antônio Silva Junior; Paulo de Tarso C de Carvalho; Regiane Albertini; Fernando C Pereira; Regiane Feliciano; Jairo Montemor; Stella S Vieira; Vanessa Grandinetti; Amanda Yoshizaki; Marcio Chaves; Móises P da Silva; Rafael do Nascimento de Lima; Danilo S Bocalini; Bruno L de Melo; Paulo J F Tucci; Andrey J Serra
Journal:  Front Physiol       Date:  2017-01-30       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.